Treatment of long-term catheter-related bloodstream infections with a taurolidine block: A single cancer center experience

Journal of Vascular Access

Volumn 12, Issue 3, 2011, Pages 244-247

  Haag, Georg Martin ^a   Berger, Anne Katrin ^a   Jäger, Dirk ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cancer; Catheter; CRBSI; Infection; Taurolidine

Indexed keywords

AMOXICILLIN; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; LEVOFLOXACIN; MOXIFLOXACIN; TAUROLIDINE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BLOOD CULTURE; CANCER CENTER; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; HUMAN; LONG TERM CARE; RECURRENT FEVER; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 80053048736     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/JVA.2011.6265     Document Type: Article

References (13)

1. Vescia S, Baumgartner AK, Jacobs VR, et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol 2008; 19: 9-15.
2. Yildizeli B, Lacin T, Batirel HF, et al. Complications and management of long-term central venous access catheters and ports. J Vasc Access 2004; 5: 174-8.
3. Pittet D, Harbarth S, Ruef C, et al. Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol 1999; 20: 37-42.
4. Richards M, Edwards JR, Culver DH, et al. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21: 510-15.
5. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
6. Messing B, Peitra-Cohen S, Debure A, et al. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1988; 12: 185-9.
7. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 2005; 55: 90-4.
8. Fortun J, Grill F, Martin-Davila P, et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 2006; 58: 816-21.
9. Gorman SP, McCafferty DF, Woolfson AD, et al. Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin O', a novel antimicrobial agent. J Appl Bacteriol 1987; 62: 315-20.
10. Simon A, Ammann RA, Wiszniewsky G, et al. Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infect Dis 2008; 8: 102.
11. Bisseling TM, Willems MC, Versleijen MW, et al. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr 2010 Jan 8. [Epub ahead of print].
12. Koldehoff M, Zakrzewski JL. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 2004; 24: 491-5.
13. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007; 7: 645-57.